Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis
Jens Devogelaere, Marie D’hooghe, Famke Vanderhauwaert, Miguel D’haeseleer
Topics & Concepts
MedicineCytokine stormRituximabDiseaseCoronavirusIntensive care medicineCase fatality rateMultiple sclerosisPandemicIntensive care unitViral pneumoniaNeurologyPneumoniaImmunologyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Internal medicineEpidemiologyPsychiatryLymphomaSARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research StudiesLong-Term Effects of COVID-19